Posted by MarketBeat News on Dec 27th, 2024
Stock analysts at StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued on Friday. The firm set a “sell” rating on the medical research company’s stock.
OpGen...
More of this article »